Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
01/2011
01/05/2011CN101936997A Human anti-rabies virus IgG antibody ELISA test kit
01/05/2011CN101936993A Porcine circovirus disease detection method based on ORF2 (Open Reading Frame 2) antigen domain
01/05/2011CN101935665A Preparation method and application of recombinant protein A gene and expression product thereof
01/05/2011CN101935664A Plants having modified growth characteristics and method for making the same
01/05/2011CN101935663A New wheat gene TaMYB3 for regulating synthetization and metabolization of anthocyanin
01/05/2011CN101935662A Toxin protein of pyemotes zhonghuajia and genes thereof
01/05/2011CN101935352A Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
01/05/2011CN101935348A Lead ion antigen and preparation method and application thereof
01/05/2011CN101935347A Deubiquitination mutant of mda-7/IL-24
01/05/2011CN101935346A Mutated human-source fibroblast growth factor and application in treating endocrine diseases
01/05/2011CN101935345A Peptides and APL-type derivatives of HSP60 and pharmaceutical compositions
01/05/2011CN101935344A Chinese housefly antibacterial peptides 1 and method for separating and purifying same
01/05/2011CN101935343A Protein related with urea absorption and coding genes and application thereof
01/05/2011CN101935342A Moth orchid development B gene-PhAP3 coded sequence and application thereof
01/05/2011CN101935341A Polypeptide with activity of inhibiting beta-lactamase and preparation method and application thereof
01/05/2011CN101935340A Prokaryotic expression protein of ORSV (Odontoglossum Ring Spot Virus) coat protein gene as well as preparation method and application thereof
01/05/2011CN101934069A Application of neuroglobin in promoting neurite growth
01/05/2011CN101934068A Preparation method of thymopetidum injection
01/05/2011CN101318989B General use artificial antigen synthesis of aminoglycoside medicaments
01/04/2011US7863506 Inbred corn line CB11
01/04/2011US7863501 Nucleotide sequences coding transcription factor for use in modifying flowering and reproduction in plants
01/04/2011US7863435 Nucleotide sequences coding transport protein; increasing fermentation concentration of threonine in grampositive bacteria
01/04/2011US7863434 Nucleotide sequences coding granulocytic ehrlichia proteins for use in diagnosis, assessment, prognosis and treatment of mammals afflicted with ehrlichiosis
01/04/2011US7863433 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
01/04/2011US7863432 Nucleic acid molecules encoding AKAP18 delta, a splice variant of a protein kinase A anchor protein
01/04/2011US7863424 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma
01/04/2011US7863423 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells
01/04/2011US7863422 monoclonal antibody inhibits CD4+ T cell, NK cell proliferation, as antiinflammatory agents in the therapeutic treatment and diagnostic detection of immune disorders in mammals; biodrugs
01/04/2011US7863420 Process for removing fibronectin from plasma fractions
01/04/2011US7863418 T cell immune response cDNA 7 (TIRC7) protein for use in treatment of organ transplantation rejection, tumor, autoimmune and/or allergic disorders
01/04/2011US7863416 Hexapeptide of given formula; binds with opioid receptor and exhibits agonist and antagonist activity; anxiolytics, diuretics, and anti-cancer agents
01/04/2011US7863413 Peptide protein translation inhibitor and the use thereof for protein translation control
01/04/2011US7863411 Comprises polypeptide, protein and/or peptide which recognize and bind to prion envelope protein for use as diagnostic tool in detecting spongiform encephalopathies; screening and removing prions from fluid products; preventing viral infection
01/04/2011US7863246 intracerebroventricular delivery of low amounts of vascular endothelial growth factor for enhancing the survival of a motor neuron in a patient diagnosed with a motoneuron disease
01/04/2011US7863245 Compositions for enhanced epithelial permeation of neuropeptide Y for treating obesity
01/04/2011US7863244 Peptides
01/04/2011US7863042 Fucose transporter
01/04/2011US7863032 Genetically engineered glucanase for use in detergent industry, textiles and preparation of peptide antibiotics
01/04/2011US7863031 Recombinant hydrolase for use in enhancing/;improving quality of animal feeds and foodstuffs
01/04/2011US7863029 Inhibiting multimeric porphobilinogen synthase; for use as drug, toothpaste, soap, disinfectant, anti-biofilm and herbicide
01/04/2011US7863027 increasing specific activity of enzyme (nitrilase) catalyst when converting glycolonitrile to glycolic acid by conducting reaction in presence of amine protectant
01/04/2011US7863019 Propagating interleukin-15 specific monoclonal antibody for use as tool in controllig immune response
01/04/2011US7863008 Hepatitis virus; detecting seroconversion; fusion proteins; capsids; immunoassay; kits
01/04/2011US7863006 Monoclonal antibody for use in detection of spongiform encephalopathy and brain disorders
01/04/2011US7862828 Allergy vaccines containing hybrid polypeptides
01/04/2011US7862827 Combination neisserial compositions
01/04/2011US7862826 treating an injury to a nervous system of an animal by applying to the injury an effective amount of an antimicrobial peptide, BDNF, IGF-1, and Substance P, wherein the antimicrobial peptide is BNP-1 and wherein the injury comprises an acute spinal cord injury
01/04/2011US7862820 Immunoglobulin chimeric monomer-dimer hybrids
01/04/2011US7862818 Using chemokine specific immunoglobulin to prevent and treat inflammatory bowel disease, colitis and/or sarcoidosis
01/04/2011US7862817 Kit to treat ErbB2-expressing cancer in patient; humanized version of monoclonal antibody 2C4; immunoconjugate of humanized antibody conjugated with a cytotoxic agent; patient produces a greater than normal level of ErbB ligand epidermal growth factor, transforming growth factor alpha
01/04/2011US7862816 Identifying ephrin inhibitors for use in treatment and prevention of cell proliferative and angiogenesis disorders; antitumor agents
01/04/2011US7862815 Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)
01/04/2011US7862814 Method of inhibiting the proliferation of B cell cancers using TACI-immunoglobulin fusion proteins
01/04/2011US7862813 Multivalent immunoglobulin polypeptide for treatment of immune system abnormalities
01/04/2011CA2573307C Use of platelet aggregation inhibitors
01/04/2011CA2553769C Npc1l1 (npc3) and methods of identifying ligands thereof
01/04/2011CA2516661C M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
01/04/2011CA2468039C Novel peptide having angiotensin converting enzyme inhibitory effect
01/04/2011CA2459013C Proteins having effects of controlling cell migration and cell death
01/04/2011CA2427658C Mutant bcl-2 proteins and uses thereof
01/04/2011CA2424332C Method of detecting norwalk-like virus (gi)
01/04/2011CA2401545C Mutated cyclin g1 protein
01/04/2011CA2392075C Method for the preparation of purified hcv rna by exosome separation
01/04/2011CA2389206C Activation of hcv-specific t cells
01/04/2011CA2388301C Modified gp100 and uses thereof
01/04/2011CA2361181C Her-2 binding antagonists
01/04/2011CA2354154C A.beta.-peptide screening assay
01/04/2011CA2350127C Avipox vector coding an hiv antigen and a cytokine
01/04/2011CA2324165C Recombinant major allergen of the pollen of artemisia vulgaris (mugwort)
01/04/2011CA2319110C Hybrid seed production
01/04/2011CA2304988C Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
01/04/2011CA2301920C Vaccine
01/04/2011CA2285018C Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
01/04/2011CA2272046C Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
01/04/2011CA2269105C Environmental stress-tolerant plants
01/04/2011CA2268865C Anti-p53 single-chain antibody fragments and their uses
01/04/2011CA2246744C Immunomodulatory complex and use thereof in diseases caused by helicobacter
01/04/2011CA2231916C Erythrocytes loaded with s-nitrosothiol and uses therefor
01/04/2011CA2163439C Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
01/04/2011CA2142575C Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
01/04/2011CA2132103C Encoded combinatorial chemical libraries
01/04/2011CA2101774C Test and model for alzheimer's disease
01/04/2011CA2068654C Varicella-zoster virus antigen
12/2010
12/30/2010US20100333236 Insect inhibiting plant serpin mutants
12/30/2010US20100333234 Transgenic Plants with Increased Stress Tolerance and Yield
12/30/2010US20100333232 transgenic plant comprising in its genome a transgene encoding a member FLOWERING LOCUS C (FLC) gene family; having early timing of its flowering; seeds; genetic engineering
12/30/2010US20100333218 Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto
12/30/2010US20100331537 Novel surface antigen
12/30/2010US20100331536 CA125 gene and its use for diagnostic and therapeutic interventions
12/30/2010US20100331529 Methods for increasing protein polyethylene glycol (peg) conjugation
12/30/2010US20100331528 Isolated Antibodies Against Biologically Active Leptin-Related Peptides
12/30/2010US20100331525 Antitumoral agents with a benzophenanthridine structure and formulations containing them
12/30/2010US20100331524 Immunomodulatory protein and useful embodiments thereof
12/30/2010US20100331523 Heterologous Protein Production Using The Twin Arginine Translocation Pathway
12/30/2010US20100331518 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants
12/30/2010US20100331263 Methods and compositions for inhibiting angiogenesis
12/30/2010US20100331262 PEPTIDE VACCINE USING MIMIC MOLECULES OF AMYLOID Beta PEPTIDE
12/30/2010US20100331261 Use of alpha-1-antitrypsin for the preparation of drugs for the treatment of chronic fatigue syndrome
12/30/2010US20100331257 Preparation of terminally-sterilized collagen that is soluble at neutral ph
12/30/2010US20100331256 Variants of C-Type Natriuretic Peptides